Diagnosis, Treatment, and Outcome of Pituitary Tumors and Other Abnormal Intrasellar Masses, Retrospective Analysis of 353 Patients
Medicine 78:236-269, Gsponer,J.,et al, 1999
Long-Term Octreotide Therapy in Growth Hormone-Secreting Pituitary Adenomas:Evaluation with Serial MR
AJNR 18:765-772, Lundin,P.,et al, 1997
Diagnosis and Management of Hormone-Secreting Pituitary Adenomas
NEJM 324:822-831, Klibanski,A.&Zervas,N.T., 1991
A 41-year-old man with Thunderclap Headache
Neurol 91:e87-e91, Grossman, S.et al, 2018
Acromegaly
NEJM 355:2558-2573, Melmed,S., 2006
Long-term Treatment of Acromegaly With Pegvisomant, a Growth Hormone Receptor Antagonist
Lancet 358:1754-1759,1743, van der Lely,A.J.,et al, 2001
Treatment of Acromegaly With the Growth Hormone-Receptor Antagonist Pegvisomant
NEJM 342:1171-1177,1210, Trainer,P.J.,et al, 2000
Pituitary Surgery for Acromegaly, Should be Done by Specialists
BMJ 319:588-589, Clayton,R.N.,et al, 1999
Management of Pituitary Tumors
Ann Int Med 129:472-483, Shimon,I.&Melmed,S., 1998
Octreotide
NEJM 334:246-254, Lamberts,S.W.J.,et al, 1996
Diagnosis and Management of Pituitary Tumours
BMJ 308:1087-1091, Levy,A.&Lightman,S.L., 1994
Effect of Octreotide, A Somatostatin Analog, on Sleep Apnea in Patients with Acromegaly
Ann Int Med 121:478-483, Grunstein,R.R.,et al, 1994
Consensus Statement:Benefits VS Risk of Medical Therapy for Acromegaly
Am J Med 97:468-473, Melmed,S.,et al, 1994
Acromegaly:Clinical and Biochemical Features in 500 Patients
Medicine 73:233-240, Ezzat,S.,et al, 1994
Acromegaly:Treatment After 100 Years
BMJ 307:1505-1506, Wass,J.A.H., 1993
Octreotide Treatment of Acromegaly, A Randomized, Multicenter Study
Ann Int Med 117:711-718, Ezzat,S.,et al, 1992
Long-term Treatment of 189 Acromegalic Patients with the Somatostatin Analog Octreotide
Arch Int Med 151:1573-1578, Vance,M.L.&Harris,A.G., 1991
Therapeutic Efficacy of the Somatostatin Analog SMS 201-995 (Octreotide) in Acromegaly
Ann Int Med 112:173-181, Ho,K.Y.,et al, 1990
Acromegaly
NEJM 322:966-977, Melmed,S., 1990
Effective & Lasting Growth-Hormone Suppres in Active Acromegaly with Oral Admin of Somatostatin Analogue SMS 201-995
Lancet 2:774-778, Williams,G.,et al, 1986
Long-Term Treatment of Acromegaly with the Somatostatin Analogue SMS 201-995
NEJM 313:1576-1580, 1604-16051985., Lamberts,S.W.J.,et al, 1985
Treatment of Acromegaly
BMJ 286:330-332, Thomas,J.P., 1983
Effect of Bromocriptine on Pituitary Tumor Size
BMJ 2:700-703, McGregor,A.M.,et al, 1979
Drug Therapy, Bromocriptine
NEJM 301:873-878, Parkes,D., 1979